Latvia vs Republic of Moldova: Share of people with HIV who receive antiretroviral therapy
Latvia
52.0%
in 2024
Republic of Moldova
53.0%
in 2024
Latvia rank
117th
Republic of Moldova rank
115th
Share of people with HIV who receive antiretroviral therapy over time
- Latvia
- Republic of Moldova
How they compare
Republic of Moldova currently reports 53.0% against 52.0% in Latvia, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Latvia ahead.
Latvia ranks 117th and Republic of Moldova ranks 115th of 143 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.2% | 1.6% | 1.6% | Latvia |
| 2010s | 22.0% | 20.4% | 1.6% | Latvia |
| 2020s | 49.8% | 46.0% | 3.8% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Latvia or Republic of Moldova?
- Republic of Moldova, at 53.0% against 52.0% in Latvia as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Latvia and Republic of Moldova?
- 1.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Latvia and Republic of Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Latvia and Republic of Moldova rank globally for share of people with hiv who receive antiretroviral therapy?
- Latvia ranks 117th and Republic of Moldova ranks 115th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.